Norway Pharmaceutical and Medical Goods Expenditure Share (2022)
Norway's Pharmaceutical and Medical Goods Expenditure Share: 10.2 % of current health expenditure in 2022, unchanged YoY.
Norway (2022)
10.2
% of current health expenditure
unchanged YoY
YoY Change
unchanged
percentage points
Trend
neutral
Series length
7
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2022 | 10.2 | unchanged |
| 2021 | 10.2 | +0.1pp |
| 2020 | 10.1 | -0.2pp |
| 2019 | 10.3 | -0.3pp |
| 2018 | 10.6 | -0.4pp |
| 2017 | 11 | +0.2pp |
| 2016 | 10.8 | n/a |
About this Dataset
Norway recorded 10.2 % of current health expenditure in 2022. That is unchanged on the previous period. Across 2016–2022 the series ranges from 10.1 in 2020 to 11 in 2017.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Norway.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Norway. It is published by Eurostat and updated annually.
The most recent observation covers 2022. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2016–2022 (7 observations).
The series peaked at 11 % of current health expenditure in 2017 and reached its lowest recorded value of 10.1 in 2020. The latest reading of 10.2 in 2022 is unchanged on the previous period.